Corrigendum: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation

Health Technol Assess. 2016 Nov;20(35):611-614. doi: 10.3310/hta20350-c201611.
No abstract available

Publication types

  • Published Erratum